Structural

Tinkering the Ticker: TandemHeart to TAVR

10 min.

High Surgical Risk Aortic Regurgitation: New TAVR Alternatives

11 min.

Aortic Stenosis With Acute LV Unloading With Septostomy

13 min.

Cardiogenic Shock: ECMO Supported TAVR

12 min.

Leaflet laceration using "Percutaneous balloon valvotomy": Utilizing UNICORN (Undermining Coronary Obstruction with Radiofrequency Needle ablation) for TAVR in TAVR.

13 min.

Case Presentation - Arkansas Heart

7 min.

The Clinical Impact and Importance of Efficient Hemodynamics with the SavvyWire®

31 min.

Why Evolut FX Design Matters

9 min.

From Portico to Navitor

15 min.

Navitor Approval Study Outcomes & Best Practices

16 min.

Perspectives of a New Navitor Implanter

13 min.

Case Presentation - Cleveland Clinic

9 min.

New Edwards TAVR Technology

12 min.

SavvyWire® to Facilitate Lifetime Patient Management and Case Efficiency with LV Pacing

10 min.

Sensor-Guided Solutions for Optimizing Outcomes without Compromise

10 min.

LVAD Associated Aortic Regurgitation: Treatment With a Dedicated TAVR System

11 min.

Surgical Updates: Surgical Aortic Valve Repair for AR

7 min.

SPOTLIGHT LECTURE: Treatment of Aortic Regurgitation Using Dedicated TAVR Systems: Early European Experience and the ALIGN AR Trial

15 min.

Stroke after TAVR: To Protect or Not to Protect?

25 min.

Clinical Data for the ACURATE Platform

16 min.

Some Newer Kids on the Block: Venus A, JenaValve, Myval, Anteris, and More…

8 min.

Update From the Clinical Trials and Where I Would and Wouldn’t Use It

14 min.

Pre-recorded Case: Navitor

11 min.

Progress in Self-Expanding TAVR: OPTIMIZE PRO and the Evolut Fx

17 min.

Progress in Balloon-Expandable TAVR: SAPIEN X4 and the ALLIANCE Trial

8 min.

Position 3: TAVR With a Supra-Annular Valve

6 min.

Position 2: TAVR With an Annular Valve

7 min.

Position 1: SAVR With Root Enlargement

10 min.

Pharmacotherapy to Prevent Calcific Aortic Stenosis: Novel Targets and Novel Study Methodologies

9 min.

Moderate AS With ‘At Risk Features: The EXPAND TAVR II Trial

9 min.

Moderate AS With ‘At Risk’ Features: The PROGRESS Trial

5 min.

Minimalist TAVR in 2023: Practical Tips and Tricks for a Safer, Less Invasive Procedure

16 min.

The Stroke Issue and When to Consider Cerebral Embolic Protection Devices (CEPD)

14 min.

An Introduction to Other New TAVR Systems (Portico Navitor, Accurate Neo 2)

11 min.

TAVR With the Self-Expanding EVOLUT FX: Procedural Technique With Case Examples

11 min.

TAVR With the Balloon-Expandable SAPIEN 3 Ultra: Procedural Techniques With Case Examples

9 min.

Cerebral Embolic Protection in TAVR - Deflection Devices

7 min.

Excision Medical Leaflet System

12 min.

SPOTLIGHT INNOVATION LECTURE: The CEP Paradox: Reconciling Clinical Evidence, Patient’s Expectations and Future Technological Developments

8 min.

Safety and Efficacy of Cerebral Embolic Protection Systems in Transcatheter Aortic Valve Replacement: A Systematic Review and Meta-analysis

18 min.

Cerebral Embolic Protection in TAVR - Full-Body Embolic Prottection Devices

14 min.

Sensor-Guided TAVR Initial experience with the SavvyWire: Post-Market Registry of the First 60 Cases

7 min.

Left Ventricle Pacing Algorithm During TAVR (Solo Pace): Program Update

10 min.

TELLTALE: Dedicated Transcatheter Electrosurgery System

6 min.

ShortCut Dedicated Aortic Leaflet Splitting Device: Clinical Experience and Emerging Indications

14 min.

Aortic Valve Lithotripsy Before TAVR: Early Human Clinical Experience

6 min.

SPOTLIGHT INNOVATION LECTURE: From BASILICA to CATHEDRAL: The Growing Role of Leaflet Modification in the Structural Heart Field

7 min.

Compassionate Use Experience with J-Valve for Native Aortic Regurgitation: First 30 Cases with a Dedicated Transfemoral System in North America

8 min.

First-in-Human XEMED TAVR Implant: An Ultra-Low Profile Modular TAVR System

8 min.

Early Clinical Experience with A New Short, Self-Expanding, Transcatheter Aortic Valve: Optimum-TAV

8 min.

DurAVR™ THV: The First-In-Class Biomimetic TAVR to Restore Normal Aortic Flow Hemodynamics-FIH Study Results

9 min.

Cerebral Embolic Protection: Why, When, and Who?

7 min.

Keynote Lecture: TAVR in AR: Anatomical Considerations for Device and Technique Selection

11 min.

JenaValve Trilogy TAVR System for the Treatment of Aortic Regurgitation: Real-World Results From a Multicenter Cohort

7 min.

DurAVR™: Design Concept and FIH Results (Anteris)

7 min.

A Completely Biological Engineered Tissue Valve for Transcatheter Heart Valve Applications (Vascudyne)

8 min.

A Novel Polymeric Leaflet Based TAVR System (Inflow)

7 min.

ShortCut: First Dedicated Transcatheter Leaflet Splitting Device (PiCardia)

8 min.

A Direct Wire Pacing Device for SHD Procedures (Electroducer Sleeve)

6 min.

New TAVR Platforms - PORTICO NAVITOR FLEX-NAV

15 min.

NEW TAVR Platforms - ACURATE NEO 2

10 min.

New TAVR Platforms - EVOLUT (OPTIMIZE and SMART)

6 min.

New TAVR Platforms - SAPIEN (X4 and ALLIANCE)

5 min.

Changing the TAVR Paradigm (Solopace)

11 min.